Clinical Trial Update: PET with [18F]Flumazenil As an Index of Neurodegeneration in MS [NA]

View source ↗

Summary

The document notes completion of a clinical trial evaluating PET imaging with the radiotracer [18F]Flumazenil as an index of neurodegeneration in multiple scler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• [18F]Flumazenil (flumazenil (radiotracer))

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis | NA | Status: COMPLETED